Company Search:
Advanced Search
Sponsored Links
Reliv' International, Inc. Company Snapshot
Reliv' International, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reliv' International with three other companies in this sector in UNITED STATES : Progenics Pharmaceuticals, Inc. (2019 sales of $34.99 million of which 100% was Biopharmaceutical), Biofrontera AG (ADR) ($34.95 million of which 100% was Pharmaceuticals), and Dynavax Technologies Corporation ($35.22 million of which 100% was Biopharmaceutical Product).

Sales Analysis. Reliv' International reported sales of $35.06 million for the year ending December of 2019. This represents a decrease of 2.9% versus 2018, when the company's sales were $36.12 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reliv' International, Inc.
  Stock Performance Chart for Reliv' International, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 3.31
(Figures in U.S. Dollars)
1 Week -2.4%   13 Weeks -9.3%  
4 Weeks -5.4%   52 Weeks -21.3%  
Reliv' International, Inc. Key Data:
  Ticker: RELV Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 35,055,315
(Year Ending Jan 2020).
Employees: 208
  Currency: U.S. Dollars Market Cap: 5,780,746
  Fiscal Yr Ends: December Shares Outstanding: 1,746,449
  Share Type: Common Closely Held Shares: 557,185
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.